Last month, Kim Kardashian endorsed a company that makes Diclegis, a morning sickness pill on her social media accounts. The story now is that the soon-to-be mom number two has gotten the attention of the Food and Drug Administration (FDA) in a wrong way, as the agency is threatening to yank her morning sickness drug of choice off the market because of her endorsement.
The problem is that Kim sings the virtues but not the risks of the drug, something the FDA requires. The FDA therefore fired off a letter to the company, asking them to stop misbranding the drug or take it off the market. The letter demands the company correct the problem by getting Kim to repost her endorsements with the proper warnings.
